Macadamia nut-specific IgE levels for predicting anaphylaxis
- PMID: 36156824
- DOI: 10.1111/pai.13852
Macadamia nut-specific IgE levels for predicting anaphylaxis
Abstract
Background: Despite the high risk of anaphylaxis in patients with a macadamia nut allergy (MdA), little is known about the significance of macadamia nut-specific immunoglobulin E (Md-sIgE). Thus, this study aimed to investigate the utility of Md-sIgE for predicting anaphylaxis.
Methods: Children with suspected MdA who visited our hospital were included. MdA was defined as either failing the 3-g macadamia nut (Md) oral food challenge (OFC) or confirming obvious immediate symptoms following Md ingestion. Non-MdA was defined as passing the 3-g Md OFC.
Results: A total of 41 children (29 [71%] males) with a median age of 7.7 years were included. The median Md-sIgE level was 2.23 kUA /L. Among the 21 children diagnosed with MdA, eight and 13 children did (An group) and did not (non-An group) develop anaphylaxis. Twenty children were included in the non-MdA group. The Md-sIgE level was significantly higher in the An group relative to the others (7.97 vs. 1.92 kUA /L, p < .001). Furthermore, the Md-sIgE level was significantly higher in the An group than in the non-An group (7.97 vs. 1.92 kUA /L, p = .02). However, there was no significant difference in the Md-sIgE between the non-An and non-MdA groups (1.92 vs. 1.90 kUA /L, p > .99). The area under the curve for predicting anaphylaxis in Md-sIgE was 0.92 (95% CI: 0.83-1.00), and the optimal cut-off value was 3.76 kUA /L.
Conclusion: Md-sIgE levels were useful in predicting anaphylaxis. Above the cut-off value, we emphasize paying careful attention to the risk of anaphylaxis.
Keywords: allergy; anaphylaxis; cut-off; diagnosis; macadamia nut; probability curve; specific IgE.
© 2022 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Stiefel G, Anagnostou K, Boyle ARJ, et al. BSACI guideline for the diagnosis and management of peanut and tree nut allergy. Clin Exp Allergy. 2017;47:719-739.
-
- Brettig T, Dang T, McWilliam V, et al. The accuracy of diagnostic testing in determining tree nut allergy: a systematic review. J Allergy Clin Immunol. 2021;9:2028-2049.
-
- McWilliam VL, Perrett KP, Dang T, et al. Prevalence and natural history of tree nut allergy. Ann Allergy Asthma Immunol. 2020;124:466-472.
-
- Brough HA, Caubet JC, Mazon A, et al. Defining challenge-proven coexistent nut and sesame seed allergy: a prospective multicenter European study. J Allergy Clin Immunol. 2020;145:1231-1239.
-
- McWilliam VC, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The prevalence of tree nut allergy: a systematic review. Curr Allergy Asthma Rep. 2015;15:54.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
